Published in Cancer on April 01, 2006
Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg (2009) 1.68
The occurrence of rare cancers in U.S. adults, 1995-2004. Public Health Rep (2010) 0.96
Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg (2015) 0.95
Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma. Radiat Oncol J (2011) 0.83
Surgical experience with retroperitoneal liposarcoma in a single korean tertiary medical center. Korean J Urol (2012) 0.81
Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol (2012) 0.80
Retroperitoneal giant liposarcoma. Korean J Urol (2010) 0.80
The role of radiation in retroperitoneal sarcomas. Curr Treat Options Oncol (2013) 0.79
Long-term outcome after multivisceral and tumor/vascular resection in patients with soft tissue sarcoma. Langenbecks Arch Surg (2008) 0.76
The role of radiotherapy in the management of localized soft tissue sarcomas. Cancer Biol Med (2016) 0.76
Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas. World J Surg Oncol (2016) 0.75
Recent advances in the management of liposarcoma. F1000Res (2016) 0.75
Primary retroperitoneal carcinosarcoma in a child: a case report. World J Surg Oncol (2010) 0.75
Inferior vena cava leiomyosarcoma: preoperative diagnosis and surgical management. Surg Case Rep (2015) 0.75
Retroperitoneal sarcoma: a rare cause of intestinal perforation in two cases. J Surg Case Rep (2011) 0.75
Retroperitoneal leiomyosarcoma presenting as lower gastrointestinal bleeding: a case report and review of the literature. Case Rep Gastrointest Med (2011) 0.75
Leiomyosarcoma of the Mesenteric Root: A Strategic Location of a Rare Tumor. Case Rep Oncol (2015) 0.75
Primary psoas sarcoma causing malignant psoas syndrome: favourable response to radiotherapy. Ann Transl Med (2017) 0.75
High-grade undifferentiated pleomorphic sarcoma of the pelvis: A case report and review of literature. Urol Ann (2016) 0.75
Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene. ISRN Urol (2011) 0.75
Neuropraxia following resection of a retroperitoneal liposarcoma. Int J Surg Case Rep (2017) 0.75
Retroperitoneal soft tissue sarcomas: experience at a single institution in Mexico. World J Surg (2010) 0.75
Effect of intraoperative radiotherapy in the treatment of retroperitoneal sarcoma. Int J Clin Oncol (2017) 0.75
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 8.69
Introduction of surgical safety checklists in Ontario, Canada. N Engl J Med (2014) 7.92
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw (2010) 5.20
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol (2006) 4.50
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work. N Engl J Med (2015) 3.88
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 3.45
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol (2006) 3.38
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg (2008) 3.36
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol (2007) 2.72
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer (2003) 2.64
Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg (2004) 2.62
Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg (2007) 2.55
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol (2006) 2.43
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol (2006) 2.42
Optimizing treatment of desmoid tumors. J Clin Oncol (2007) 2.27
Modified Makuuchi incision for foregut procedures. Arch Surg (2010) 2.15
Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol (2002) 2.13
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol (2006) 2.12
Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.11
The management of patients with T1 adenocarcinoma of the low rectum: a decision analysis. Dis Colon Rectum (2013) 2.07
Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum (2005) 2.04
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer (2012) 2.01
Angiosarcoma of the breast. Cancer (2005) 1.98
Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg (2005) 1.84
The learning curve in pancreatic surgery. Surgery (2007) 1.84
Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res (2003) 1.81
Resection of some -- but not all -- clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol (2008) 1.79
Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients. Ann Surg Oncol (2007) 1.78
Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol (2008) 1.77
Volume-outcome relationship for coronary artery bypass grafting in an era of decreasing volume. Arch Surg (2008) 1.70
Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol (2006) 1.69
Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Cancer Epidemiol (2013) 1.69
Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer (2002) 1.67
Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc (2012) 1.67
Mortality rate after nonelective hospital admission. Arch Surg (2011) 1.67
Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol (2014) 1.67
Surgical therapy for anorectal melanoma. J Am Coll Surg (2003) 1.65
Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg (2007) 1.62
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg (2003) 1.58
The status of radical proctectomy and sphincter-sparing surgery in the United States. Dis Colon Rectum (2007) 1.55
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol (2006) 1.52
Developing a research agenda for the American Society of Colon and Rectal Surgeons: results of a delphi approach. Dis Colon Rectum (2009) 1.52
Novel applications of endo GIA linear staplers during pancreaticoduodenectomy and total pancreatectomy. Am J Surg (2003) 1.51
Does breast reconstruction after mastectomy for breast cancer affect overall survival? Long-term follow-up of a retrospective population-based cohort. Plast Reconstr Surg (2015) 1.47
Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol (2002) 1.47
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg (2003) 1.45
Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol (2004) 1.41
Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol (2003) 1.41
Surgical management of intrahepatic cholangiocarcinoma--a population-based study. Ann Surg Oncol (2007) 1.39
A matter of race: early-versus late-stage cancer diagnosis. Health Aff (Millwood) (2009) 1.38
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol (2010) 1.38
Carcinoid tumors of the duodenum. Surgery (2005) 1.37
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol (2013) 1.36
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther (2007) 1.36
Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol (2006) 1.35
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer (2002) 1.34
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer (2011) 1.32
Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg (2009) 1.27
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol (2008) 1.26
Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg (2012) 1.24
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer (2011) 1.24
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg (2007) 1.24
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer (2003) 1.24
Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg (2004) 1.24
Long-term results of anterior sphincteroplasty. Dis Colon Rectum (2004) 1.23
Staging and preoperative evaluation of upper gastrointestinal malignancies. Semin Oncol (2004) 1.22
ACCO: ASCO core curriculum outline. J Clin Oncol (2005) 1.20
Retroperitoneal sarcomas. Cancer Control (2005) 1.20
Neoadjuvant therapy for resectable pancreatic cancer. Surg Oncol Clin N Am (2004) 1.18
Adjuvant therapy for resected gastric cancer--rapid, yet incomplete adoption following results of intergroup 0116 trial. Int J Radiat Oncol Biol Phys (2007) 1.18
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer (2006) 1.17
Lymph node evaluation in early-stage colon cancer. Clin Colorectal Cancer (2008) 1.14
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.13
Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg (2005) 1.13
Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg (2008) 1.12
Reducing variation in surgical care. BMJ (2005) 1.10
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys (2006) 1.10
Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck (2008) 1.09
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) (2012) 1.09
Venous resection in pancreatic cancer surgery. Best Pract Res Clin Gastroenterol (2006) 1.09
Surgical management of soft tissue sarcomas of the hand and foot. Cancer (2002) 1.07
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys (2003) 1.06
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer (2002) 1.06
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.05
The management of fistula-in-ano: a plea for randomized trials and standard reporting of case series with adequate follow-up. Dis Colon Rectum (2013) 1.05
Monitoring surgical mortality. BMJ (2005) 1.04
Disparate use of minimally invasive surgery in benign surgical conditions. Surg Endosc (2008) 1.04
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg (2011) 1.03
Is the effectiveness of colonoscopy "good enough" for population-based screening? J Natl Cancer Inst (2009) 1.03
Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods. Can J Public Health (2013) 1.03
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg (2013) 1.03
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol (2006) 1.02
Tumor volume as a prognostic factor for sarcomatosis. Cancer (2002) 1.02
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg (2012) 1.01